Accueil / Communiqués / The Global ELISpot and FluoroSpot Assay Market by Product, Application and End-user – Forecast to 2023, Expecting to Reach $287 Million – ResearchAndMarkets.com

The Global ELISpot and FluoroSpot Assay Market by Product, Application and End-user – Forecast to 2023, Expecting to Reach $287 Million – ResearchAndMarkets.com

Thursday, December 13th 2018 at 11:23am UTC
The ELISpot and FluoroSpot market is projected to reach USD 287 million
by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the
forecast period.
The rising global incidence of chronic diseases, increasing vaccine
development to address the challenge of antimicrobial resistance, and
technological advancements in ELISpot and FluoroSpot assay kits and
analyzers, are factors expected to drive market growth during the
forecast period. The use of FluoroSpot assays for multiple-analyte
detection in a single well is also expected to provide opportunities for
the growth of the market.

By product, in 2018, the assay kits segment is expected to account for
the largest market share. This segment is also expected to grow at the
highest CAGR during the forecast period. The rising incidence of chronic
diseases and technological advancements are driving the growth of this
product segment.

On the basis of application, in 2018, the diagnostics segment is
expected to account for the larger share of the ELISpot and FluoroSpot
market. The large share of this segment can be attributed to the rising
global prevalence of infectious diseases and the increasing use of
ELISpot kits for disease diagnosis.

Market Dynamics

Drivers

  • Rising Global Incidence of Chronic Diseases
  • Increasing Vaccine Development to Address the Challenge of
    Antimicrobial Resistance
  • Technological Advancements in ELISpot and FluoroSpot Assay Kits and
    Analyzers

Opportunities

  • Use of FluoroSpot Assays for Multiple-Analyte Detection in a Single
    Well

Challenges

  • Availability of Alternative Detection Technologies

Key Topics Covered

1 Introduction 2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 ELISpot and FluoroSpot Market, By Product

7 ELISpot and FluoroSpot Market, By Application

8 ELISpot and FluoroSpot Market, By End User

9 ELISpot and FluoroSpot Market, By Region

10 Competitive Landscape

11 Company Profiles

  • Abcam
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Bio-Techne
  • Biotech Investissement Group
  • Cellular Technology Limited (CTL)
  • Lophius Biosciences GmbH
  • Mabtech AB
  • Oxford Immunotec
  • U-Cytech Biosciences

For more information about this report visit https://www.researchandmarkets.com/research/ps87rp/the_global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Source: Research and Markets


Voir aussi

Maverick Therapeutics to Unveil Pre-Clinical Data on Novel COBRATM Platform at American Association for Cancer Research 2019 Annual Meeting

Saturday, March 30th 2019 at 12:00pm UTC – Pre-clinical Data Characterize the Conditional and Potent …